|
Re: Oh great,,, the .16 centers Are out again.......IMO
|
18
|
Mosaic ImmunoEngineering Inc.
|
Dec 14, 2012 08:01PM
|
|
Re: Still no PR on Markman results.
|
9
|
Mosaic ImmunoEngineering Inc.
|
Dec 10, 2012 10:16AM
|
|
Re: I didn't dredge up the past, another poster wrote a brief backround
|
6
|
Mosaic ImmunoEngineering Inc.
|
Dec 09, 2012 02:51PM
|
|
Acer's Opposition to TPL's Motion is now in . . .
|
4
|
Mosaic ImmunoEngineering Inc.
|
Dec 17, 2012 09:20PM
|
|
Re: Just an FYI . . . Grewal denied TPL's motion to . . Here is entire text
|
2
|
Mosaic ImmunoEngineering Inc.
|
Dec 19, 2012 01:44PM
|
|
Re: Sierra Wireless
|
2
|
Mosaic ImmunoEngineering Inc.
|
Dec 14, 2012 08:01AM
|
|
Re: Jimmybond
|
2
|
Mosaic ImmunoEngineering Inc.
|
Dec 10, 2012 10:12AM
|
|
Re: The appearnce of Recurring Royalties
|
2
|
Mosaic ImmunoEngineering Inc.
|
Dec 14, 2012 06:38PM
|
|
Re: Section 4.1 of the license agreement....moxa
|
2
|
Mosaic ImmunoEngineering Inc.
|
Dec 16, 2012 08:02AM
|
|
Re: Section 4.1 of the license agreement
|
2
|
Mosaic ImmunoEngineering Inc.
|
Dec 16, 2012 08:10AM
|
|
Re: So is the long awaited PR now a moot point?
|
2
|
Mosaic ImmunoEngineering Inc.
|
Dec 13, 2012 12:11AM
|
|
Re: Question about long form
|
2
|
Mosaic ImmunoEngineering Inc.
|
Dec 12, 2012 08:10AM
|
|
Re: Question about long form
|
1
|
Mosaic ImmunoEngineering Inc.
|
Dec 11, 2012 07:47AM
|
|
Re: Still no PR on Markman results....Bill
|
1
|
Mosaic ImmunoEngineering Inc.
|
Dec 10, 2012 10:23AM
|
|
Re: "Material event"
|
1
|
Mosaic ImmunoEngineering Inc.
|
Dec 12, 2012 09:00PM
|
|
Re: Section 4.1 of the license agreement....moxa
|
1
|
Mosaic ImmunoEngineering Inc.
|
Dec 16, 2012 09:20AM
|
|
Re: Relief payments
|
1
|
Mosaic ImmunoEngineering Inc.
|
Dec 16, 2012 10:08AM
|
|
Re: Markman
|
1
|
Mosaic ImmunoEngineering Inc.
|
Dec 10, 2012 08:41AM
|
|
Re: Email from Sierra Wireless CFO ...
|
1
|
Mosaic ImmunoEngineering Inc.
|
Dec 15, 2012 07:42AM
|
|
Re: So is the long awaited PR now a moot point?
|
|
Mosaic ImmunoEngineering Inc.
|
Dec 14, 2012 07:55AM
|
